Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000058482) titled 'A nationwide multi-institutional retrospective study to examine predictors of early postoperative recurrence in anatomically resectable pancreatic cancer treated with neoadjuvant chemotherapy (NAC-GS) (NAC-PIONEER trial)' on Aug. 1.
Study Type: Observational
Study Design:
Not selected Not selected
Primary Sponsor: University of Toyama
Condition:
Resectable pancreatic cancer
Recruitment Status: Not Recruiting
Phase: Not selected
Date of First Enrollment: 2025/08/01
Target Sample Size: 5500
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cg...